Your browser doesn't support javascript.
loading
Health-related quality of life in outpatients with substance use disorder: evolution over time and associated factors.
Simirea, Melexima; Baumann, Cédric; Bisch, Michael; Rousseau, Hélène; Di Patrizio, Paolo; Viennet, Sarah; Bourion-Bédès, Stéphanie.
Afiliação
  • Simirea M; Centre Psychothérapique de Nancy, CSAPA (Health Care Centre of Accompaniment and Prevention in Addictology), 54 520, Laxou, France. alina.simirea@yahoo.com.
  • Baumann C; UMDS (Unit of Methodology, Data Management and Statistics), University Hospital of Nancy, 54500, Vandoeuvre-lès-Nancy, France.
  • Bisch M; EA4360 APEMAC (Health Adjustment, Measurement and Assessment, Interdisciplinary Approaches) MICS Team, University of Lorraine, 54500, Vandoeuvre-lès-Nancy, France.
  • Rousseau H; Centre Psychothérapique de Nancy, CSAPA (Health Care Centre of Accompaniment and Prevention in Addictology), 54 520, Laxou, France.
  • Di Patrizio P; UMDS (Unit of Methodology, Data Management and Statistics), University Hospital of Nancy, 54500, Vandoeuvre-lès-Nancy, France.
  • Viennet S; Centre Psychothérapique de Nancy, CSAPA (Health Care Centre of Accompaniment and Prevention in Addictology), 54 520, Laxou, France.
  • Bourion-Bédès S; Centre Psychothérapique de Nancy, CSAPA (Health Care Centre of Accompaniment and Prevention in Addictology), 54 520, Laxou, France.
Health Qual Life Outcomes ; 20(1): 26, 2022 Feb 16.
Article em En | MEDLINE | ID: mdl-35172824
ABSTRACT

BACKGROUND:

Health-related quality of life (HRQoL) is an important element of patient care and clinical research. The aim of this study was to describe HRQoL changes and identify associated factors during a 6-month follow-up of outpatients starting care for alcohol or opioid dependence.

METHODS:

HRQoL was measured at baseline and 3 and 6 months later using the SF-12. Data on the patients' sociodemographics, clinical characteristics and levels of anxiety and depression were collected using the Hospital Anxiety and Depression Scale (HADS). Repeated-measures analyses were performed to assess factors associated with global HRQoL differences and the evolution of HRQoL indicated by both physical and mental scores (PCS and MCS, respectively).

RESULTS:

The mean PCS and MCS scores were initially low at 45.4 (SD = 8.6) and 36.0 (SD = 10.9), respectively. The improvement in HRQoL was rapid in the first 3-month period and then slowed and remained stable over the subsequent 3-month period. Being employed (p = 0.012), having no comorbidities (p = 0.014) and having no depression (p = 0.004) were associated with significant differences in the average PCS scores at the 3 time points. Patients who had lower overall HRQoL MCS scores on average were those for whom a medication was initiated (p = 0.009), as was the case for patients with anxiety (p < 0.001) and depression (p < 0.001). Patients with depression at baseline were also those for whom a significantly greater increase in MCS score during the 6 months of follow-up was observed.

CONCLUSION:

Our findings highlight the importance of screening early psychological distress and considering other factors associated with HRQoL changes in outpatients after the first 3-month period of treatment for substance use disorder.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Transtornos Relacionados ao Uso de Substâncias Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Transtornos Relacionados ao Uso de Substâncias Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article